Evidence map›Paper›PMID 28143966›Full record

ReviewJournal of the American Society of Nephrology : JASN2017

Renal Aging: Causes and Consequences.

Eoin D O'Sullivan, Jeremy Hughes, David A Ferenbach

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 281 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
281citing papers in PubMed, 6 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

281 citing papers in PubMed, 6 syntheses or guidelines pooled it, 470 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Preclinical models versus clinical renal ischemia reperfusion injury: A systematic review based on metabolic signatures.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

221 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Eoin D O'SullivanDepartment of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom; eoindosullivan@gmail.com.
Jeremy HughesDepartment of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
David A FerenbachDepartment of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Edinburgh Royal Infirmary · GBMetabolism and Renal Physiology · FRQueen's Medical Centre · GB

Funding

Medical Research Council G0901697Wellcome Trust
6 · The paper itself

Abstract

Individuals age >65 years old are the fastest expanding population demographic throughout the developed world. Consequently, more aged patients than before are receiving diagnoses of impaired renal function and nephrosclerosis-age-associated histologic changes in the kidneys. Recent studies have shown that the aged kidney undergoes a range of structural changes and has altered transcriptomic, hemodynamic, and physiologic behavior at rest and in response to renal insults. These changes impair the ability of the kidney to withstand and recover from injury, contributing to the high susceptibility of the aged population to AKI and their increased propensity to develop subsequent progressive CKD. In this review, we examine these features of the aged kidney and explore the various validated and putative pathways contributing to the changes observed with aging in both experimental animal models and humans. We also discuss the potential for additional study to increase understanding of the aged kidney and lead to novel therapeutic strategies.

Indexed as

AgingBiomedical ResearchCell CycleCell HypoxiaForecastingHumansKidneyMaleOxidative StressRenal Insufficiency, ChronicSignal TransductionAgingglomerulosclerosiskidney dysfunctionmetabolismmolecular biologyprogression of renal failure

Identifiers

PMID28143966
PMCPMC5280008
OpenAlexW2551259303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.